Skip to content

Efficacy of 3 times Effective Dose 95 vs 6 times Effective Dose 95 dose of Cisatracurium with Magnesium Sulphate for endotracheal intubation in patients undergoing general anaesthesia.

EFFICACY OF 3ED95 VS 6ED95 DOSE OF CISATRACURIUM WITH MAGNESIUM SULPHATE FOR ENDOTRACHEAL INTUBATION IN PATIENTS UNDERGOING GENERAL ANAESTHESIA, A RANDOMIZED DOUBLE BLINDED STUDY. - nil

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/068788
Enrollment
70
Registered
2024-06-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: EFFICACY OF 3ED95 VS 6ED95 DOSE OF CISATRACURIUM WITH MAGNESIUM SULPHATE: EFFICACY OF 3ED95 VS 6ED95 DOSE OF CISATRACURIUM WITH MAGNESIUM SULPHATE FOR ENDOTRACHEAL INTUBATION For a dura

Sponsors

Aarupadai veedu medical college and hospital.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age group from 18 to 65 years ASA I and ASA II Elective surgeries under general anaesthesia

Exclusion criteria

Exclusion criteria: Patient refusal to participate in the study Patients taking magnesium supplements Patients with arrhythmias Patients with neuromuscular diseases Patients on beta blockers or antiarrhythmic drugs Patients using medications that influence neuromuscular functions (e.g., calcium channel blockers, phenytoin, aminoglycosides) Electrolytes abnormalities Hepatic or renal insufficiency Pregnant and breastfeeding women Patients with known allergies to medications used in the study

Design outcomes

Primary

MeasureTime frame
To compare the ideal intubation conditions of two different ED95 doses (3ED95 Vs 6ED95) of Cisatracurium with Magnesium SulphateTimepoint: 3 minutes

Secondary

MeasureTime frame
To determine the ease of intubation Duration of action of intubating dose Total dose of Cisatracurium used in each group Hemodynamics ComplicationsTimepoint: 5 minutes

Countries

India

Contacts

Public ContactDr Sathish kumar Gnanadoss

Aarupadai veedu medical college and hospital.

ezhilrajan96@gmail.com9843030074

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026